S&P 500   3,168.22 (-0.01%)
DOW   28,137.80 (+0.02%)
QQQ   207.22 (+0.34%)
AAPL   274.91 (+1.27%)
AMZN   1,763.46 (+0.18%)
NVDA   224.78 (+0.32%)
MU   51.26 (+0.57%)
GE   11.38 (-0.52%)
TSLA   357.77 (-0.53%)
T   38.22 (-0.34%)
AMD   41.34 (-2.93%)
ACB   2.64 (+1.54%)
F   9.23 (-0.97%)
PRI   136.15 (-0.26%)
NFLX   298.20 (-0.08%)
BAC   34.46 (-0.63%)
GILD   65.67 (-2.90%)
DIS   146.67 (-0.74%)
S&P 500   3,168.22 (-0.01%)
DOW   28,137.80 (+0.02%)
QQQ   207.22 (+0.34%)
AAPL   274.91 (+1.27%)
AMZN   1,763.46 (+0.18%)
NVDA   224.78 (+0.32%)
MU   51.26 (+0.57%)
GE   11.38 (-0.52%)
TSLA   357.77 (-0.53%)
T   38.22 (-0.34%)
AMD   41.34 (-2.93%)
ACB   2.64 (+1.54%)
F   9.23 (-0.97%)
PRI   136.15 (-0.26%)
NFLX   298.20 (-0.08%)
BAC   34.46 (-0.63%)
GILD   65.67 (-2.90%)
DIS   146.67 (-0.74%)
S&P 500   3,168.22 (-0.01%)
DOW   28,137.80 (+0.02%)
QQQ   207.22 (+0.34%)
AAPL   274.91 (+1.27%)
AMZN   1,763.46 (+0.18%)
NVDA   224.78 (+0.32%)
MU   51.26 (+0.57%)
GE   11.38 (-0.52%)
TSLA   357.77 (-0.53%)
T   38.22 (-0.34%)
AMD   41.34 (-2.93%)
ACB   2.64 (+1.54%)
F   9.23 (-0.97%)
PRI   136.15 (-0.26%)
NFLX   298.20 (-0.08%)
BAC   34.46 (-0.63%)
GILD   65.67 (-2.90%)
DIS   146.67 (-0.74%)
S&P 500   3,168.22 (-0.01%)
DOW   28,137.80 (+0.02%)
QQQ   207.22 (+0.34%)
AAPL   274.91 (+1.27%)
AMZN   1,763.46 (+0.18%)
NVDA   224.78 (+0.32%)
MU   51.26 (+0.57%)
GE   11.38 (-0.52%)
TSLA   357.77 (-0.53%)
T   38.22 (-0.34%)
AMD   41.34 (-2.93%)
ACB   2.64 (+1.54%)
F   9.23 (-0.97%)
PRI   136.15 (-0.26%)
NFLX   298.20 (-0.08%)
BAC   34.46 (-0.63%)
GILD   65.67 (-2.90%)
DIS   146.67 (-0.74%)
Log in

NYSE:ALB - Albemarle Stock Price, Forecast & News

$66.56
-1.46 (-2.15 %)
(As of 12/13/2019 03:34 PM ET)
Today's Range
$66.34
Now: $66.56
$68.44
50-Day Range
$60.56
MA: $65.43
$71.33
52-Week Range
$58.63
Now: $66.56
$93.14
Volume987,029 shs
Average Volume1.10 million shs
Market Capitalization$7.06 billion
P/E Ratio12.15
Dividend Yield2.24%
Beta1.64
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. Read More…

Industry, Sector and Symbol

Industry Plastics materials & resins
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
CUSIP01265310
Phone980-299-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.37 billion
Cash Flow$7.64 per share
Book Value$35.40 per share

Profitability

Net Income$693.56 million

Miscellaneous

Employees5,900
Market Cap$7.06 billion
Next Earnings Date2/19/2020 (Estimated)
OptionableOptionable

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.


Albemarle (NYSE:ALB) Frequently Asked Questions

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, October 29th. Stockholders of record on Friday, December 13th will be given a dividend of $0.368 per share on Thursday, January 2nd. This represents a $1.47 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Thursday, December 12th. This is a positive change from Albemarle's previous quarterly dividend of $0.37. View Albemarle's Dividend History.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) released its earnings results on Wednesday, November, 6th. The specialty chemicals company reported $1.53 EPS for the quarter, topping analysts' consensus estimates of $1.49 by $0.04. The specialty chemicals company earned $879.70 million during the quarter, compared to analysts' expectations of $883.67 million. Albemarle had a return on equity of 15.94% and a net margin of 16.27%. The company's revenue was up 13.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. View Albemarle's Earnings History.

When is Albemarle's next earnings date?

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Albemarle.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle updated its FY 2024 Pre-Market earnings guidance on Thursday, December, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.4-5 billion.

What price target have analysts set for ALB?

21 brokerages have issued 12 month price objectives for Albemarle's stock. Their forecasts range from $39.50 to $128.00. On average, they expect Albemarle's share price to reach $78.73 in the next twelve months. This suggests a possible upside of 18.0% from the stock's current price. View Analyst Price Targets for Albemarle.

What is the consensus analysts' recommendation for Albemarle?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 8 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

Has Albemarle been receiving favorable news coverage?

Press coverage about ALB stock has been trending positive recently, according to InfoTrie. The research group ranks the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Albemarle earned a daily sentiment score of 2.1 on InfoTrie's scale. They also gave media headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Albemarle.

Are investors shorting Albemarle?

Albemarle saw a decrease in short interest in the month of November. As of November 29th, there was short interest totalling 16,330,000 shares, a decrease of 8.2% from the November 14th total of 17,780,000 shares. Based on an average daily trading volume, of 1,510,000 shares, the short-interest ratio is presently 10.8 days. Approximately 15.5% of the shares of the company are short sold. View Albemarle's Current Options Chain.

Who are some of Albemarle's key competitors?

What other stocks do shareholders of Albemarle own?

Who are Albemarle's key executives?

Albemarle's management team includes the folowing people:
  • Mr. Luther C. Kissam IV, Chairman, Pres & CEO (Age 54)
  • Mr. Scott A. Tozier, Exec. VP & CFO (Age 53)
  • Mr. Donald J. LaBauve Jr., VP, Corp. Controller & Chief Accounting Officer (Age 52)
  • Ms. Karen G. Narwold, Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 59)
  • Mr. David Ryan, VP of Corp. Strategy & Investor Relations

Who are Albemarle's major shareholders?

Albemarle's stock is owned by a variety of of retail and institutional investors. Top institutional investors include State Street Corp (6.84%), SPF Beheer BV (1.01%), KAMES CAPITAL plc (0.62%), Sumitomo Mitsui Trust Holdings Inc. (0.46%), Eagle Asset Management Inc. (0.35%) and Commerzbank Aktiengesellschaft FI (0.34%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Institutional Ownership Trends for Albemarle.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Man Group plc, Carillon Tower Advisers Inc., Pictet Asset Management Ltd., Investment Management of Virginia LLC, SPF Beheer BV, Synovus Financial Corp and Gs Investments Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Insider Buying and Selling for Albemarle.

Which major investors are buying Albemarle stock?

ALB stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Foundry Partners LLC, Miller Howard Investments Inc. NY, Commerzbank Aktiengesellschaft FI, KAMES CAPITAL plc, CIBC Private Wealth Group LLC, California Public Employees Retirement System and Capital Management Corp VA. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $66.69.

How big of a company is Albemarle?

Albemarle has a market capitalization of $7.07 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.

What is Albemarle's official website?

The official website for Albemarle is http://www.albemarle.com/.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]


MarketBeat Community Rating for Albemarle (NYSE ALB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  646 (Vote Outperform)
Underperform Votes:  529 (Vote Underperform)
Total Votes:  1,175
MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote "Outperform" if you believe ALB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel